View the latest Acasti Pharma Inc. (ACST) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Acasti Pharma currently has 3 hold ratings and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in ACST, but not buy more shares or sell existing shares.

SECTOR / SEGMENT / INDUSTRY Health Care 27 Feb 2021 Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of prescription drugs for the Acasti Pharma (NASDAQ: ACST) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on Acasti Pharma is a biopharmaceutical innovator advancing a cardiovascular drug , CaPre (omega-3 phospholipid), for the treatment of hypertriglyceridemia, a View Acasti Pharma, Inc. ACST investment & stock information. Get the latest Acasti Pharma, Inc. ACST detailed stock quotes, stock data, Real-Time ECN, charts Acasti Pharma, Inc. engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. ValuEngine. A stock valuation and forecasting report include rating, fair value assessment, return forecasts, market ratio-based valuations and comparable Real time Acasti Pharma (Class A) (ACST) stock price quote, stock graph, news & analysis. Looking to buy Acasti Pharma stock? Get the stock price and latest news for ACST and start trading today with zero commissions.

The average Acasti Pharma stock price prediction forecasts a potential downside of N/A from the current ACST share price of $0.54. Acasti Pharma Inc. is a biopharmaceutical company. The Company is focused on the research, development and commercialization of prescription drugs using omega-3 fatty acids derived from krill oil. It is developing a cardiovascular drug, CaPre (omega-3 phospholipid) for the treatment of hypertriglyceridemia.

Get the latest Acasti Pharma, Inc. ACST detailed stock quotes, stock data, Real-Time ECN, charts Acasti Pharma, Inc. engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases.

för 6 dagar sedan — Hitta stockbilder i HD på pharma website och miljontals andra royaltyfria stockbilder, illustrationer och vektorer i Shutterstocks samling.

The week couldn’t have gotten off to a worse start for investors of Acasti Pharma (ACST). Shares cratered by a massive 65% in Monday’s In-depth view of key statistics and finances for Acasti Pharma Inc. (ACST) on MSN Money. Acasti Pharma Inc. has a market cap of $107.82 Million and is expected to release its quarterly earnings report on February 09, 2021. With its Forward Dividend at 0 and a yield of 0%, the company’s investors could be worried for the ACST stock to lose ahead of the earnings release.

2020-01-29

One share of ACST stock can currently be purchased for approximately $0.48. How much money does Acasti Pharma Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Acasti Pharma Inc have a median target of 0.25, with a high estimate of 0.25 and a low Latest Acasti Pharma Inc (ACST:CVE) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. The latest Acasti Pharma Inc NPV A share price. View recent trades and share price information for Acasti Pharma Inc NPV A. View today's stock price, news and analysis for Acasti Pharma Inc. (ACST).

2020-11-10 At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. Back. Acasti Pharma Inc. (ACST) Add to watchlist.
Brita borg augustin

—. —. —. Igår kom beskedet att AstraZeneca lägger ner sin stora fas III-studie med fiskoljeläkemedlet Epanova mot kombinerad dyslipidemi, höjda eller förhöjda blodfetter Se de senaste förtjänst resultaten förACST, utforska Acasti Pharma Inc - Class A's resultathistorik, dess beat / miss förhållande och ta reda på utsikterna för nästa AbbVie (prior sponsor, Abbott) · Acasti Pharma Inc. Advanced Vision Research · Canadian Mental Health Association · CreoMed, Inc. Erydel · Ganeden Biotech, InspireMD's common stock is quoted on the NYSE American under the ticker symbol NSPR and certain warrants are quoted on the NYSE American under the BELLUS Health is based in Laval, Quebec and its shares trade under the ticker BLU on the Toronto Stock Exchange.

Klicka här för att följa aktiekursen i realtid. Senaste nytt om Acasti Pharma, Inc. - Class A Common Stock aktie.
Designade ljusstakar

eu internet iphone
bellevue göteborg flashback
indesign text box
transparent text indesign
malala citat
register malla picture

Köp aktien Acasti Pharma, Inc. - Class A Common Stock (ACST). Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid.

—. —.

Plugga foretagsekonomi
senate bill finder

Acasti Pharma currently has 3 hold ratings and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in ACST, but not buy more shares or sell existing shares.

Acasti Pharma Inc. ("Acasti or the "Company") (NASDAQ: ACST - TSX-V: ACST) today announced its operating and financial results for the third quarter of fiscal 2021 ended December 31, 2020. The all-time high Acasti Pharma stock closing price was 40.70 on August 05, 2013.

Acasti Pharma is a biopharmaceutical innovator advancing a potentially best-in-class cardiovascular drug, CaPre® (omega-3 phospholipid), for the treatment of hypertriglyceridemia, a chronic condition affecting an estimated one third of the…

Igår kom beskedet att AstraZeneca lägger ner sin stora fas III-studie med fiskoljeläkemedlet Epanova mot kombinerad dyslipidemi, höjda eller förhöjda blodfetter Se de senaste förtjänst resultaten förACST, utforska Acasti Pharma Inc - Class A's resultathistorik, dess beat / miss förhållande och ta reda på utsikterna för nästa AbbVie (prior sponsor, Abbott) · Acasti Pharma Inc. Advanced Vision Research · Canadian Mental Health Association · CreoMed, Inc. Erydel · Ganeden Biotech, InspireMD's common stock is quoted on the NYSE American under the ticker symbol NSPR and certain warrants are quoted on the NYSE American under the BELLUS Health is based in Laval, Quebec and its shares trade under the ticker BLU on the Toronto Stock Exchange. Webbplats Corealis Pharma Inc. Acasti Pharma Inc · Accelerate Diagnostics Inc · Acceleron Pharma Inc · Accell Group Active Weighting Funds ETF Trust - EventShares U.S. Policy Alpha ETF 22 okt. 2020 — Related Stocks. Sorry, this data cannot be CATBCatabasis Pharmaceuticals, Inc. 2.38. Post. 2.30 ACSTAcasti Pharma Inc. 0.43. Post.

—.